- Home
- ERAS vs DC Comparison
ERAS vs DC Comparison
Compare ERAS & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- DC
- Stock Information
- Founded
- ERAS 2018
- DC 2017
- Country
- ERAS United States
- DC United States
- Employees
- ERAS N/A
- DC N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- DC Precious Metals
- Sector
- ERAS Health Care
- DC Basic Materials
- Exchange
- ERAS Nasdaq
- DC Nasdaq
- Market Cap
- ERAS 484.4M
- DC 410.9M
- IPO Year
- ERAS 2021
- DC N/A
- Fundamental
- Price
- ERAS $1.58
- DC $4.18
- Analyst Decision
- ERAS Strong Buy
- DC Buy
- Analyst Count
- ERAS 6
- DC 1
- Target Price
- ERAS $4.50
- DC $9.00
- AVG Volume (30 Days)
- ERAS 714.7K
- DC 559.3K
- Earning Date
- ERAS 08-12-2025
- DC 08-13-2025
- Dividend Yield
- ERAS N/A
- DC N/A
- EPS Growth
- ERAS N/A
- DC N/A
- EPS
- ERAS N/A
- DC N/A
- Revenue
- ERAS N/A
- DC N/A
- Revenue This Year
- ERAS N/A
- DC N/A
- Revenue Next Year
- ERAS N/A
- DC N/A
- P/E Ratio
- ERAS N/A
- DC N/A
- Revenue Growth
- ERAS N/A
- DC N/A
- 52 Week Low
- ERAS $1.01
- DC $2.05
- 52 Week High
- ERAS $3.31
- DC $4.48
- Technical
- Relative Strength Index (RSI)
- ERAS 53.64
- DC 60.23
- Support Level
- ERAS $1.44
- DC $3.87
- Resistance Level
- ERAS $1.64
- DC $4.25
- Average True Range (ATR)
- ERAS 0.10
- DC 0.15
- MACD
- ERAS 0.01
- DC 0.02
- Stochastic Oscillator
- ERAS 61.54
- DC 86.27
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.